Skip to main content

Advertisement

Log in

Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience

  • Clinical-Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Patients with diffuse pontine gliomas have a median survival of less than one year and represent a challenge for pediatric oncologists, prompting them to attempt experimental therapies. From 1987 to 2005, 62 children with diffuse pontine glioma, not amenable to curative surgery, were treated according to four successive pilot protocols: (1) concomitant chemo–radiotherapy (etoposide, cytarabine, ifosfamide, cisplatin, and dactinomycin); (2) intensive high-dose courses chemotherapy (cisplatin/etoposide, cyclophosphamide/vincristine/methotrexate) and a subsequent course of myeloablative thiotepa followed by radiation and maintenance chemotherapy; (3) cisplatin/etoposide followed by isotretinoin before, during and after focal irradiation; and (4) iv vinorelbine before, during, and after irradiation. Considering all patients, 77% experienced a transient response to treatment, always detectable after radiotherapy. The progression-free survival (PFS) rate was 25 ± 6% at one year, median PFS was seven months; overall survival (OS) was 45 ± 6%, median OS was eleven months: no statistical differences in the four studies in terms of outcome were detected. Despite improved diagnostic, therapeutic, and supportive tools in pediatric neuro-oncology, little has been achieved for patients with diffuse pontine tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Albright AL, Packer RJ, Zimmerman R et al (1999) Magnetic resonance scan should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029

    Article  Google Scholar 

  2. Shiminski-Maher T, Abbot R, Wisoff JH, Epstein FJ (1991) Current trends in the management of brainstem tumors in childhood. J Neurosci Nurs 23:356–362

    PubMed  CAS  Google Scholar 

  3. Benesch M, Lackner H, Moser A et al (2001) Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas. Pediatr Neurosurg 35:173–180

    Article  PubMed  CAS  Google Scholar 

  4. Korones DN (2007) Treatment of newly diagnosed diffuse brain stem gliomas in children: in search of the holy grail. Expert Rev Anticancer Ther 7:663–674

    Article  PubMed  Google Scholar 

  5. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248

    Article  PubMed  Google Scholar 

  6. Massimino M, Gandola L, Casanova M et al (2000) Concomitant chemoradiotherapy for childhood poor-prognosis gliomas. Med Pediatr Oncol 34:147–150

    Article  PubMed  CAS  Google Scholar 

  7. Massimino M, Gandola L, Luksch R et al (2005) Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 7:41–48

    Article  PubMed  CAS  Google Scholar 

  8. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  9. Peto R, Peto J (1972) Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A] 135:185–207

    Article  Google Scholar 

  10. Massimino M, Simonetti F, Balestrini MR, Spreafico F et al (2006) Transitory, spontaneously recovering, peripheral facial nerve palsy after vinorelbine administration. Neurol Sci 27:110–113

    Article  PubMed  CAS  Google Scholar 

  11. Langmoen IA, Lundar T, Storm-Mathisen I et al (1991) Management of pediatric pontine gliomas. Childs Nerv Syst 7:13–15

    Article  PubMed  CAS  Google Scholar 

  12. Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266–1272

    Article  PubMed  CAS  Google Scholar 

  13. Mandell LR, Kadota R, Freeman C et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brain stem tumors: results of a pediatric oncology group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959–964

    Article  PubMed  CAS  Google Scholar 

  14. Doz F, Neuenschwander S, Bouffet E et al (2002) Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d’Oncologie Pédiatrique. Eur J Cancer 38:815–819

    Article  PubMed  CAS  Google Scholar 

  15. Schwaofer JH, Crooijmans RP, Hoogenhout J, Kal HB, Theeuwes AG (1991) Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 20:1235–1241

    Google Scholar 

  16. Freeman CR, Kepner J, Kun LE et al (2000) A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Radiat Oncol Biol Phys 47:561–564

    Article  PubMed  CAS  Google Scholar 

  17. Dunkel IJ, O’Malley B, Finlay JL (1996) Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood? Pediatr Neurosurg 24:263–266

    Article  PubMed  CAS  Google Scholar 

  18. Bouffet E, Raquin M, Doz F et al (2000) Radiotherapy followed by high dose busulfan and thiotepa. A prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88:685–692

    Article  PubMed  CAS  Google Scholar 

  19. Massimino M, Spreafico F, Cefalo G et al (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209–4216

    Article  PubMed  CAS  Google Scholar 

  20. Kretschmar CS, Tarbell N, Barnes P et al (1993) Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. Cancer 72:1404–1413

    Article  PubMed  CAS  Google Scholar 

  21. Bouterfa H, Picht T, Kess D et al (2000) Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. Neurosurgery 46:419–430

    Article  PubMed  CAS  Google Scholar 

  22. Yung WKA, Kyritsis AP, Gleason MJ et al (1996) Treatment of recurrent malignant gliomas with high dose 12-cis-retinoic acid. Clin Cancer Res 2:1031–1935

    Google Scholar 

  23. Puduvalli VK, Saito Y, Xu R et al (1999) Fenretinide activates caspases and induces apoptosis in gliomas. Clin Cancer Res 5:2230–2235

    PubMed  CAS  Google Scholar 

  24. Hanley ML, Elion GB, Colvin OM et al (1998) Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors. Cancer Chemother Pharmacol 42:479–482

    Article  PubMed  CAS  Google Scholar 

  25. Binet S, Fellous A, Lataste H et al (1989) In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence. Semin Oncol 16(Suppl 4):5–8

    PubMed  CAS  Google Scholar 

  26. Curran WJ (2002) New chemotherapeutic agents: update of major chemoradiation trials in solid tumors. Oncology 63(Suppl 2):29–38

    Article  PubMed  CAS  Google Scholar 

  27. Biassoni V, Casanova M, Spreafico F, Gandola L, Massimino M (2006) A case of relapsing glioblastoma multiforme responding to vinorelbine. J Neurooncol 80:195–201

    Article  PubMed  CAS  Google Scholar 

  28. Wagner S, Warmuth-Metz M, Emser A et al (2006) Treatment options in childhood pontine gliomas. J Neurooncol 79:281–287

    Article  PubMed  Google Scholar 

  29. Kornreich L, Schwarz M, Karmazyn B et al (2005) Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature Pediatr Radiol 35:872–879

    Article  PubMed  Google Scholar 

  30. Gilbertson RJ, Hill DA, Hernan R (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem gliomas. Clin Cancer Res 9:3620–3624

    PubMed  CAS  Google Scholar 

  31. Bode U, Buchen S, Warmuth-Metz M, Pietsch T, Bach F, Fleischhack G (2007) Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings; (abstract) 25, 18S (June 20 Supplement)

Download references

Acknowledgements

The authors are indebted to the Associazione “Bianca Garavaglia”, Busto Arsizio, Milano, for partial financial support (scholarships).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maura Massimino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Massimino, M., Spreafico, F., Biassoni, V. et al. Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87, 355–361 (2008). https://doi.org/10.1007/s11060-008-9525-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9525-5

Keywords

Navigation